Home/CHO-plus/Joseph Tarnowski
JT

Joseph Tarnowski

Chief Technology and Business Officer

CHO-plus

CHO-plus Pipeline

DrugIndicationPhase
Engineered CHO Cell LinesTherapeutic Protein Manufacturing (Monoclonal Antibodies)Commercial Feasibility Testing
Engineered HEK-293 Cell LinesViral Vector Manufacturing (AAV)Commercial Feasibility Testing